Genmab says Q3 2026 net sales of DARZALEX total USD 4.24 billion
Genmab reported worldwide net trade sales of DARZALEX of USD 4.24 billion in the third quarter of 2026. U.S. net trade sales reached USD 2.53 billion; rest-of-world sales totaled USD 1.71 billion. Royalty income tied to worldwide DARZALEX net sales reported by Johnson & Johnson under Genmab’s license agreement. Disclai